心肌梗死后超额死亡与预期寿命损失:一项登记匹配队列研究
研究显示年轻、女性及左室射血分数(LVEF)降低者预期寿命损失(LOLE)更高,但校正合并症和危险因素后减弱;30年间调整后平均LOLE下降36%至55%,且未见明显平台期。
要点
- 年轻、女性及LVEF<50%的心梗患者预期寿命损失更高。
- 2022年调整后平均LOLE从50岁女性LVEF降低者的9.5年至80岁男性LVEF保留者的3.7个月不等。
- 1992至2022年调整后平均LOLE下降36%至55%,未见明显平台期。
核心结论
- 年轻、女性和LVEF降低的心梗患者预期寿命损失更高,但校正合并症和危险因素后减弱。
- 过去30年心梗治疗进步使调整后平均预期寿命损失几乎减半,且未见明显平台期。
研究设计与样本
- 基于瑞典SWEDEHEART全国登记,纳入1991至2022年首次心梗患者,按年龄、性别和居住地区与最多5名无既往心梗对照匹配。
- 采用灵活参数生存模型估计超额死亡和平均预期寿命损失(LOLE),并根据指数年份、年龄、性别和LVEF分析,校正特征差异。
主要发现
- 年轻个体、女性和LVEF<50%者观察到更高的LOLE。
- 2022年,未调整和调整后平均LOLE范围从50岁女性LVEF降低者的11.1年和9.5年至80岁男性LVEF保留者的5个月和3.7个月。
- 1992至2022年间,调整后平均LOLE下降36%至55%:50岁女性和男性分别从4.4年降至2.0年、从3.3年降至1.9年;80岁女性和男性分别从1.7年降至1.0年、从1.4年降至0.9年。
临床怎么用
- 临床应关注年轻、女性及LVEF降低的心梗患者,其预期寿命损失更高。
- 尽管心梗后预期寿命损失随时间改善,但仍需持续优化治疗以进一步降低损失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of myocardial infarction (MI) on life expectancy is difficult to study because the prevalence of MI hinders direct comparison with the life expectancy of the general population. We sought to assess this in relation to age, sex, and left ventricular ejection fraction (LVEF) by comparing individuals with MI with matched comparators without previous MI. METHODS: We included patients with a first MI between 1991 and 2022 from the nationwide SWEDEHEART registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies), each matched with up to 5 comparators on age, sex, and region of residence. Flexible parametric survival models were used to estimate excess mortality and mean loss of life expectancy (LOLE) depending on index year, age, sex, and LVEF, and adjusted for differences in characteristics. RESULTS: A total of 335 748 cases were matched to 1 625 396 comparators. A higher LOLE was observed in younger individuals, women, and those with reduced LVEF (<50%). In 2022, the unadjusted and adjusted mean LOLE spanned from 11.1 and 9.5 years in 50-year-old women with reduced LVEF to 5 and 3.7 months in 80-year-old men with preserved LVEF. Between 1992 and 2022, the adjusted mean LOLE decreased by 36% to 55%: from 4.4 to 2.0 years and from 3.3 to 1.9 years in 50-year-old women and men, respectively, and from 1.7 to 1.0 years and from 1.4 to 0.9 years in 80-year-old women and men, respectively. CONCLUSIONS: LOLE is higher in younger individuals, women, and those with reduced LVEF, but is attenuated when adjusting for comorbidities and risk factors. Advances in MI treatment during the past 30 years have almost halved LOLE, with no clear sign of leveling off to a plateau.
引用
- Reitan, Andell, Alfredsson, et al. Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study. Circulation. 2024. PMID: 38966988. doi:10.1161/CIRCULATIONAHA.124.068739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。